USPTO serial 98153632
ZOLL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 11, 2026
- Examiner
- MASULLO, MARCO
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ZOLL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Chelmsford, MA, US
Chelmsford, MA, US
Chelmsford, MA, US
Chelmsford, MA, US
Chelmsford, MA, US
Chelmsford, MA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Debra S. Serota
Debra S. Serota FISH & RICHARDSON P.C.P.O. BOX 1022MINNEAPOLIS, MA 55440-1022United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software for use in wearable electronic devices for monitoring and recording, storing, and transmitting biometric data, ECG information, radio-frequency based physiological information, thoracic fluid information, heart rate, respiration rate, patient activity, and patient posture information | ACTIVE | Sep 10, 2018 |
| 010 | Medical devices, namely, ventilators, automatic resuscitators, aspirators, vacuum pumps, suction devices; cardiac monitors; medical devices used for chest compression and automated chest compression in cardiac resuscitation; medical component parts, featuring software for instantaneous feedback and information regarding ventilation, for use with medical ventilation units, namely, bag-valve masks (BVMs); medical devices used to perform active compression decompression cardiopulmonary resuscitation; medical devices intended to improve perfusion in spontaneously breathing patients with a pulse; emergency medical aid kits comprised of tourniquets, occlusive chest seals, nitrile gloves, medical dressings, and shears; first aid kits for the treatment of medical emergencies for use with an interactive mobile application; medical devices for use in providing clinical decision support guidance and physiological closed loop control treatment; medical devices, namely, wearable electronic devices for patient monitoring and recording, storing, and transmitting of medical information, namely, ECG information, radio-frequency based physiological information, thoracic fluid information, heart rate, respiration rate, patient activity, and patient posture information; temperature management systems comprised primarily of controllers, pumps, and heat exchangers for controlling the temperature of working fluid flowing through catheters, externally-applied heat exchange pads for medical use or heat exchangers for medical use; heat exchangers to cool or warm working fluid from intravascular temperature management catheters for medical use; heat exchangers to cool or warm working fluid from externally-applied heat exchange pads for medical use; externally-applied heat exchange pads for medical use; heat exchangers for medical use, temperature management tubing for medical use; intravascular heat exchange catheters; medical apparatus and instruments, namely, catheters, pump systems, and tubing for the preparation and delivery of physiologic solutions used to treat conditions, namely, tissue ischemia and post-ischemic tissues; non-invasive, diagnostic units used to assess and measure body functions and states and physiological conditions which affect the vasculature; medical testing kits consisting primarily of medical devices for measuring peripheral arterial tone, finger probes and computer software for the non-invasive monitoring, assessment, diagnosis and treatment of sleep disorders; medical devices for monitoring and managing respiratory rhythm, namely, implantable rhythm managers, leads, patient wands and programmers; medical leads, namely, cardiac leads, leads for introducing and delivering medical devices and media to the vascular system; wearable devices for monitoring, recording, storing of, and transmitting biometric data, ECG information, radio-frequency based physiological information, thoracic fluid information, heart rate, respiration rate, patient activity, and patient posture information; parts, accessories and components for medical devices, namely, infusion pumps, oxygen concentrators, and blood warmers; parts, accessories, and components for the foregoing medical devices | ACTIVE | Dec 6, 2016 |
| 042 | Software as a service (SaaS) services featuring software for patient data management; software as a service (SaaS) services featuring software to manage and integrate data about self-pay and high deductible patients in EMS, medical, and healthcare fields for automated revenue optimization; software as a service (SaaS) services featuring software for providing clinical charting, compliance, decision analytics and privacy management and practice management used in the field of medical transportation services; software as a service (SaaS) services featuring software for health information exchange solutions; software as a service (SaaS) services featuring software for managing the monitoring, assessment, diagnosis and treatment of sleep disorders; providing medical research and medical research information in the field of sleep apnea and heart failure treatment; medical research | ACTIVE | Dec 31, 2015 |
| 044 | Providing medical information on cardiac health and cardiac events; providing medical information for medical professionals and medical patients that is collected from devices at remote locations, processed, and made available to users through a website | ACTIVE | Dec 31, 2006 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ZOLL Medical Corporation
- Other trademarks owned by ZOLL Medical Corporation
- Other trademarks owned by ZOLL Medical Corporation
- Other trademarks owned by ZOLL Medical Corporation
- Other trademarks owned by ZOLL Medical Corporation
- Other trademarks owned by ZOLL Medical Corporation
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ZOLL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 11, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 11, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 22, 2026 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jul 22, 2026 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jul 21, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| May 12, 2026 | IUAF | USE AMENDMENT FILED | — |
| May 12, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Apr 25, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 24, 2026 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Apr 24, 2026 | EXT2 | SOU EXTENSION 2 FILED | — |
| Apr 24, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 24, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 23, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 23, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 23, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 29, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 4, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 4, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 26, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 7, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 7, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 7, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 7, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 7, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 7, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 7, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 7, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 4, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 4, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 4, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 4, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 4, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 4, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 5, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 5, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 5, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 6, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 6, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 6, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 26, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 26, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 31, 2023 | NWAP | NEW APPLICATION ENTERED | — |